<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>TATA box abnormality in the promoter region of the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi> glucuronosyltransferase 1 gene has been reported to cause <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> in white subjects </plain></SENT>
<SENT sid="1" pm="."><plain>It has also been reported that the majority of Japanese patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> are heterozygous for Gly71Arg in the coding region of this gene </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, some patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> often show signs of unexpected <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aims of this study were to determine which of the genetic variations, TATA box genotype or codon 71 genotype, is most closely related to serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations, and whether the TATA box genotype has an effect on serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations in patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C-associated <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In a sample of 300 individuals selected from among the general Japanese population, mean concentrations of total serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> differed significantly among TATA box genotypes, but not among codon 71 genotypes </plain></SENT>
<SENT sid="5" pm="."><plain>Concentration of total serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> was significantly correlated with TATA box genotypes </plain></SENT>
<SENT sid="6" pm="."><plain>In 211 patients with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C-associated <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e>, mean concentrations of total serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> also differed significantly among TATA box genotypes </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C, concentration of total serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> was significantly correlated with TATA box genotypes </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, TATA box genotypes, but not codon 71 genotypes, are closely related to serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations </plain></SENT>
<SENT sid="9" pm="."><plain>TATA box genotypes should therefore be considered when evaluating hepatic function by serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations in cases of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C-associated <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e> </plain></SENT>
</text></document>